Equities

Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc

Actions
  • Price (EUR)5.35
  • Today's Change0.10 / 1.90%
  • Shares traded0.00
  • 1 Year change+16.30%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments575632551
Total Receivables, Net56147118
Total Inventory514352
Prepaid expenses182620
Other current assets, total------
Total current assets700848740
Property, plant & equipment, net22311795
Goodwill, net326284153
Intangibles, net221217118
Long term investments------
Note receivable - long term------
Other long term assets18244.36
Total assets1,4872,2821,918
LIABILITIES
Accounts payable115.998.15
Accrued expenses575129
Notes payable/short-term debt000
Current portion long-term debt/capital leases6.075.446.00
Other current liabilities, total144850
Total current liabilities8711094
Total long term debt551522525
Total debt557527531
Deferred income tax----0
Minority interest373360230
Other liabilities, total59745755
Total liabilities1,0711,7371,603
SHAREHOLDERS EQUITY
Common stock2.512.552.55
Additional paid-in capital129138128
Retained earnings (accumulated deficit)286405185
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total----0
Total equity417545315
Total liabilities & shareholders' equity1,4872,2821,918
Total common shares outstanding251255255
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.